Skip to main content
Top
Published in: Reactions Weekly 1/2019

01-11-2019 | Dasabuvir | Case report

Dasabuvir/ombitasvir/paritaprevir/ritonavir

Various toxicities: 2 case reports

Published in: Reactions Weekly | Issue 1/2019

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Londono M-C, et al. Effectiveness, safety/tolerability of OBV/PTV/r +/- DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice-Vie-KinD study. PLOS One 14: No. 9, 24 Sep 2019. Available from: URL: http://doi.org/10.1371/journal.pone.0221567 - SpainCrossRef Londono M-C, et al. Effectiveness, safety/tolerability of OBV/PTV/r +/- DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice-Vie-KinD study. PLOS One 14: No. 9, 24 Sep 2019. Available from: URL: http://​doi.​org/​10.​1371/​journal.​pone.​0221567 - SpainCrossRef
Metadata
Title
Dasabuvir/ombitasvir/paritaprevir/ritonavir
Various toxicities: 2 case reports
Publication date
01-11-2019
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2019
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-70967-1

Other articles of this Issue 1/2019

Reactions Weekly 1/2019 Go to the issue

Case report

Betamethasone

Case report

Crizotinib

Case report

Rivoceranib